Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Despite Ozempic being the most recognisable brand name, as far as the people prescribing it are concerned weight loss is ...

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...

Lars Fruergaard Jørgensen, the boss of Danish pharmaceutical giant Novo Nordisk, explained what impact the drugs can have on users weight in the long run ...

Novo Nordisk’s earnings stood at DKK 29.03 billion ... On the other hand, Q1 sales of diabetes drug Ozempic hit DKK 32.72 billion, easily surpassing analysts’ consensus of DKK 31.5 billion. The U.S.

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...

A doctor has issued an warning as to why Ozempic shouldn't be used for weight loss as it does one alarming thing to body.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

It’s been nicknamed “Ozempic feet,” when those shedding pounds on the injectable drugs find that the skin on their feet is ...

Novo Nordisk, which also makes Wegovy, fell victim to 'compounding' - a practice in the US that allows pharmacies to produce ...

Wall Street stocks finished modestly higher Wednesday as the Federal Reserve kept interest rates unchanged while markets cautiously greeted news of weekend US-China trade talks.